ACER THERAPEUTICS INC (ACER) Stock News
NASDAQ:ACER - Nasdaq - US00444P1084 - Common Stock - Currency: USD
ACER Latest News, Press Relases and Analysis
Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
Bayer's Phase 3 study OASIS 3 findings on elinzanetant, a promising non-hormonal treatment for menopausal hot flashes. Results show significant reduction in symptoms over 12 weeks, marking a potential breakthrough in menopause management.
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals
Acer Shareholders – Please Vote Today!...
Moore Kuehn Encourages TWNK, LVOX, ACER, and PNT Investors to Contact Law Firm
/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, HT, ABCM, ACER
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Health Care Company Zevra Therapeutics Announces Merger With Acer Therapeutics
Mentions: ZVRA
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ABCM, AGE, ACER, NXGN
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WRK, AGE, ACER
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates THRN, ABCM, AGE, ACER
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Shareholder Alert: Ademi LLP investigates whether Acer Therapeutics Inc. has obtained a Fair Price in its transaction with Zevra
/PRNewswire/ -- Ademi LLP is investigating Acer (Nasdaq: ACER) for possible breaches of fiduciary duty and other violations of law in its transaction with...
Shopify (SHOP) Stock Jumps 6% on Amazon Deal
Shopify (SHOP) stock is on the rise Thursday as investors react to a deal between it and e-commerce giant Amazon (AMZN).
ACER Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Acer Therapeutics Inc. Is Fair to Shareholders
Why Is Axcella Health (AXLA) Stock Down 21% Today?
Axcella Health (AXLA) stock is falling on Thursday following a rally from its announcement of a new Covid-19 treatment patent.
Why Is Acer Therapeutics (ACER) Stock Up 85% Today?
Acer Therapeutics (ACER) stock is taking off on Thursday after the company announced an acquisition deal with Zevra Therapeutics (ZVRA).
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time for another breakdown of the biggest pre-market stock movers as we dive into all of the latest news for Thursday!
Acer Therapeutics will reacquire OLPRUVA rights from Relief Therapeutics (NASDAQ:ACER)
Pharmaceutical company Acer Therapeutics (ACER) will reacquire worldwide development, commercialization and economic rights to OLPRUVA (sodium phenylbutyrate) from Relief...
Acer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA™ from Relief Therapeutics, Excluding the Geographical Europe
NEWTON, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development...
Acer Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
OLPRUVA™ (sodium phenylbutyrate) kits now available in all dosage strengths and ready to ship to patients...